Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $30.53. The company's market cap stands at 174.04B, with a P/E ratio of 39.66 and a dividend yield of 5.74%.
During the trading session on 2026-10-30, Pfizer(PFE) shares reached a daily high of $30.64 and a low of $30.28. At a current price of $30.53, the stock is +0.8% higher than the low and still -0.3% under the high.
Trading activity shows a volume of 2.22M, compared to an average daily volume of 27.71M.
The stock's 52-week range extends from a low of $23.62 to a high of $30.64.
The stock's 52-week range extends from a low of $23.62 to a high of $30.64.
PFE News
Investing Pfizer Yields Nearly 6%, but Its Dividend Exceeds Free Cash Flow. Is It Safe? Pfizer's dividend yield sits near 6%, but the company paid out more in d...
Heavy spending on artificial intelligence by giants like Amazon and Intel is starting to pinch cash flows and spook parts of the market. That short term worry c...
...
Analyst ratings
62%
of 29 ratingsMore PFE News
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's ear...
Pfizer (NYSE:PFE) reported that ELREXFIO met its primary endpoint of progression free survival in a pivotal Phase 3 trial in relapsed or refractory multiple mye...
Pfizer Inc. (NYSE:PFE) on Tuesday released topline results from its Phase 3 MagnetisMM-32 study evaluating Elrexfio (elranatamab) as a monotherapy. • Pfizer st...
Three companies in pharmaceuticals, energy, and tobacco operate in entirely different worlds, and that separation is exactly the point for retirees who need the...
Investing Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady Moderna's personalized melanoma vaccine cleared its prima...
Pfizer (PFE) is keeping its experimental lung cancer drug alive despite a failed clinical trial. New data showed that some patients treated with sigvotatug vedo...
Pfizer reported detailed Phase 2 data for its 25-valent pneumococcal conjugate vaccine in infants, showing robust immune responses across all 25 serotypes with...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.